Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714].
McBane RD 2nd, Loprinzi CL, Zemla T, Tafur A, Sanfilippo K, Liu JJ, Garcia DA, Heun J, Gundabolu K, Onitilo AA, Perepu U, Drescher MR, Henkin S, Houghton D, Ashrani A, Billett H, Mooberry MJ, McCue SA, Lee MK, Le-Rademacher JG, Wysokinski WE; EVE trial investigators.
McBane RD 2nd, et al. Among authors: drescher mr.
J Thromb Haemost. 2024 Dec 20:S1538-7836(24)00731-1. doi: 10.1016/j.jtha.2024.12.011. Online ahead of print.
J Thromb Haemost. 2024.
PMID: 39709266
No abstract available.